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Abstract 
Background: Behavioral activation (BA) is an effective treatment for depression in the 
general adult population but it is unclear if it is effective for older people.  
Aims: To systematically review randomised controlled trials (RCTs) of BA for 
depression in older people.  
Method: We searched MEDLINE, EMBASE, PsycINFO, CINAHL and on line trial 
registers for RCTs of BA for depression in older people.  
Results: Eighteen trials were included in the meta-analyses. BA reduced mean 
depression scores for older people living in the community as a stand-alone treatment 
(standardised mean difference (SMD) -0.72; 95% confidence interval (CI) -1.04 to -0.41). 
It was also effective as part of a multicomponent intervention (SMD -0.44; 95% CI -0.56 
to -0.32).   
Conclusions: BA significantly reduces depressive symptoms in older people in the 
community, however given most studies are small and with significant bias results should 
be interpreted with caution. Further high quality trials of BA for older people are needed.    
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     Depression in older people is a prevalent and disabling condition with major 
depressive disorder affecting approximately 5-15% of older people living in the 
community (1). Estimates of prevalence of mild symptoms of depression, often referred 
to as subsyndromal depression (SSD) are much higher ranging from 5% to 37% (2). 
Untreated symptoms even when mild, can contribute to poor physical and psychiatric 
outcomes such as increasing the number and severity of medical illness, and the risk of 
developing major depression (3). Depression diminishes older adults’ quality of life, 
exacerbates functional deficits, and increases risk of morbidity and mortality (4). 
Depression is the major contributor of poor outcomes in older people contributing heavily 
to healthcare costs (5). Depression in late life is often under detected and untreated (1), 
and may be resistant to antidepressants (6). Many studies of psychological treatments 
have few or no older participants. It is estimated that preventing and treating depressive 
symptoms in older people may result in significantly reduced health care utilisation and 
cost savings (7). With an increasing ageing population it is important to find out what 
strategies are effective for managing depression for older people and addressing needs of 
those with cognitive impairment. 
     Behavioral explanations of low mood and depressive affect are rooted in learning 
theory models of depression, which argue that increasing positively reinforcing 
behaviors, leads to more positive consequences for individuals, thereby improving mood 
(8). The lack of events associated with positive outcomes in the person’s environment is a 
key contributor to the emergence or maintenance of depressive symptoms (9). According 
to behavioral models of depression in late life (10), depressive symptoms may be 
intensified or maintained by the absence of positive feelings resulting from participation 
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in enjoyable and meaningful activity. Interventions, therefore, that target activities may 
theoretically be particularly helpful in preventing or treating depression in older people.  
     Behavioral activation (BA) is an effective treatment for depression for adults, with 
recent studies indicating that it is as effective as Cognitive Behavioral Therapy (CBT), 
and potentially less costly (11). Despite evidence of clinical effectiveness for younger 
adults, evidence of effectiveness for older people is less clear. Although there are several 
studies evaluating BA in older people, there are no systematic reviews bringing the 
evidence together. In the present paper, our aim was to evaluate worldwide evidence on 
the clinical effectiveness of BA for depression in older people and report on its quality.  
Method 
     We searched all related BA and behavior therapy terms in MEDLINE, EMBASE, 
CINHAL, PsycINFO and the Cochrane library for ongoing trials, national and 
international trial registers, and specialised databases of psychological treatments of 
depression (www.evidencebasedpsychotherapies.org) to December 2017 (see 
Supplementary On line Material for details of search terms). We scanned reference lists 
of all included studies and 136 reviews relevant to the area identified by the search 
(psychological therapies in older people with or without cognitive impairment/dementia).   
     Inclusion criteria were: (1) RCTs comparing BA with treatment as usual (or any other 
treatment), (2) older people (aged ≥ 55) in any setting (community, inpatient or long-term 
care), (3) studies in older people with or without cognitive impairment or dementia, (4) 
outcome was either depressive symptoms or depression remission. Secondary outcomes 
were function, quality of life and anxiety symptoms. 
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     We defined BA as a brief structured psychotherapeutic approach that aimed to: 
increase engagement in adaptive activities (often associated with pleasure and mastery) 
through a) structured activity scheduling and b) monitoring of mood (association of mood 
and activities), and/or other behavioral strategies such as relaxation/stress reduction 
techniques, social skills enhancement, or hierarchical construction of goals (12). Some 
studies also included additional interventions. Activity interventions which did not satisfy 
these criteria or had a high exercise component were defined as BA-related. We divided 
interventions according to where they took place (community, inpatient/24 hour care 
settings, care homes); and by short term (4-12 weeks) or long term effectiveness (8-12 
months). We also tested whether publication bias was present.      
     Two reviewers (VO, JB) worked independently to identify RCTs that met the 
inclusion criteria, and extracted data independently. Disagreements were discussed with 
the third author (GL). We contacted authors of primary trials if there were missing data. 
We employed the Cochrane Handbook for Systematic Reviews of Interventions approach 
for assessing risk of bias (addressing the domains of sequence generation, allocation 
concealment, blinding, incomplete outcome data, selective reporting and other issues). 
We used a random-effects model to represent overall estimate effects, and standardised 
mean differences when studies used different outcome scales. We quantified 
heterogeneity by using the I2 statistic. All calculations were conducted using Review 
Manager (RevMan) 5.2 for Windows (Cochrane Collaboration, Oxford UK; www.cc-
ims.net/RevMan). We used the GRADE approach to summarise overall quality of 
evidence. We performed a sensitivity meta-analysis on high quality studies only.  
Results 
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   We identified 7248 references through database searching, with thirty three additional 
references identified via other sources (see Figure 1 Study flow chart). After removal of 
duplicates and clearly irrelevant articles, we retrieved 391 full text records. Of these 327 
were excluded at this stage as not relevant, leaving 64 full text references to be fully 
assessed for eligibility. Of these, 36 studies were excluded as not meeting inclusion 
criteria (see Table 2 of Excluded Studies Supplementary On line Material), because they 
evaluated BA in family carers (8 studies); were not RCTs (14 studies); the intervention 
did not fulfil our criteria of BA (12 studies); there was no control comparison group (1 
study), and data were not available (1 study). A total of 28 studies were eligible for 
inclusion, of which 7 are ongoing (13-19)  (see Supplementary On line Material Table 1 
for main study characteristics including description of elements of interventions).   
Description of studies 
            We were able to pool data from 18 studies. There were 9 studies in older people 
living in the community, 3 RCTs in inpatient settings, and 6 studies in older people living 
in care homes of whom some had cognitive impairment. We pooled data from 5 RCTs on 
BA only (20-24; community settings), and 4 trials on multicomponent BA (25-28; 
community settings) for depressive symptoms. All of the multicomponent BA studies 
provided data on remission of symptoms. We pooled data from all 3 RCTs evaluating BA 
in inpatient settings (29-31), and all the 6 studies of BA in older people living in care 
homes (32-37). Although there were three studies in people with dementia that aimed to 
increase activity, none of these met the inclusion criteria. These studies were in 
community-dwelling people with dementia, and evaluated interventions with a strong 
physical activity component and activity scheduling was not structured. We classified 
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these as BA-related (38-40). We judged these studies as too different to be pooled in a 
meta-analysis. We used the Chi² test to detect and report on heterogeneity.  
Primary outcomes 
Depressive symptoms 
      Meta-analysis on effects of BA on depressive symptoms, showed that results 
significantly favoured BA (5 studies, 175 participants, standardised mean difference 
(SMD) -0.72; 95% confidence interval (CI) -1.04 to -0.41, efficacy at 4-12 weeks) in 
reducing depressive symptoms for older people living in the community (with a diagnosis 
of depression or subthreshold depressive symptoms), with no heterogeneity between the 
studies (I2 = 0%) (see Figure 2). Multicomponent BA reduced depressive symptoms in 
comparison to treatment as usual, in the short term (4 studies, 2523 participants, SMD -
0.44; 95% CI -0.56 to -0.32, efficacy at 3-6 months, Figure 3), but not long-term (4 
studies, 2300 participants, SMD -0.30; 95% CI -0.59 to 0.00, efficacy at 8-12 months, 
Figure 4). There was moderate (I2 = 39%) to high heterogeneity (I2 = 88%) in both of 
these analyses.        
Remission of depressive symptoms  
      Multicomponent BA improved remission of depressive symptoms both short term (3 
studies, 2733 participants, odds ratio (OR) 2.66, 95% CI 1.46 to 4.87, efficacy at 3-6 
months, I2 = 81%, Figure 5 Supplementary On line Material), and long-term (3 studies, 
2458 participants, OR 3.06, 95% CI 1.94 to 4.82, efficacy at 8-12 months, I2 = 63%, 
Figure 6 Supplementary On line Material).  
     BA in inpatient and long-term care settings 
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     We found no significant differences between the intervention and treatment as usual 
groups for older people in psychiatric inpatient (3 studies, 74 participants, SMD -0.11; 
95% CI -0.57 to 0.35, efficacy at 2-8 weeks, I2 = 0%), or long-term care settings (6 
studies, 302 participants with and without dementia, SMD -0.43; 95% CI -0.87 to 0.01, 
efficacy at 6-12 weeks, I2 = 65%).      
Secondary outcomes 
Quality of life, function and anxiety symptoms 
Multicomponent BA improved quality of life compared to treatment as usual (2 studies, 
1806 participants, SMD 0.33; 95% CI 0.12 to 0.54, efficacy at 3-6 months, I2 = 54%), and  
decreased functional disability for older people living in the community (2 studies, 1806 
participants, SMD -0.24; 95% CI -0.33 to -0.15, efficacy at 3-6 months, I2 = 0%). There 
was a significant effect of multicomponent BA in comparison to treatment as usual, on 
reduction of anxiety symptoms in the short term (2 studies, 761 participants, SMD -0.30; 
95% CI -0.44 to -0.15, efficacy at 4 months, I2 = 0%), which was not maintained at long-
term follow-up (2 studies, 739 participants, SMD -0.16; 95% CI -0.38 to 0.06, efficacy at 
8-12 months, I2 = 43%).       
None of the studies reported or described adverse events. 
Quality of studies   
Risk of bias, publication bias and overall quality of evidence  
     Bias was detected predominantly in the domains of sequence generation and allocation 
concealment, with one study being at high risk in the domain of blinding of outcome 
assessment (for detailed ratings see Figure 7 Supplementary On line Material). We 
assessed publication bias via a funnel plot (Figure 8 Supplementary On line Material) 
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which appeared to be approximately symmetrical, indicating no association between 
standardised effect size and standard errors of effects, confirmed by the Egger’s test (t = -
1.326; P = 0.203). Using the GRADE approach, the overall quality of evidence of 
effectiveness of BA for depressive symptoms was judged as moderate.  
We also considered the potential bias and overestimation of effects by running analyses 
only on high quality studies as judged by predetermined criteria used in previous meta-
analyses of psychotherapy trials (41). Only studies on multicomponent BA (4 studies) 
and BA in care homes (3 studies) qualified to be included in the analyses which showed 
that the SMD was -0.40; 95% CI -0.48 to -0.32, I2 = 48% (7 studies, 2676 participants).      
Discussion 
      In this study, we aimed to establish the most up-to-date and accurate estimate of 
effectiveness of BA for older people. We also evaluated the quality of the evidence and 
presence of publication bias. We found that overall there is evidence of effects for both 
BA and multicomponent BA, in the range usually regarded as clinically significant (42), 
ranging from SDM = 0.40 to SDM = 1.05 for BA and SDM = 0.37 to SDM = 0.81 for 
multicomponent BA for older people living in the community. When only high quality 
studies on BA and multi-component BA were considered the effect size was still 0.4.   
Five RCTs with a total of 175 participants (96 receiving behavioral activation, 79 
treatment as usual) showed that BA reduces depressive symptoms in community dwelling 
older people. These results compare favorably with studies of CBT for depression in 
older people, and are in line with recent data on comparable effectiveness of BA in all 
adults (11). However, given the paucity of trials and methodological limitations, there is 
still some uncertainty about this result.     
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     Three studies showed that multicomponent BA approaches benefit older people in the 
community with symptom remission in the short term and approximately a year later. In 
terms of symptom reduction, multicomponent BA approaches were effective only short-
term, with differences no longer being significant in the longer-term, indicating that 
effects are less stable. Further studies are required to confirm these results.         
     Our analyses did not find that adding other care components such as case management 
or collaborative care adds to effectiveness of BA approaches and this is similar to 
evidence in adult depression (43). Only multicomponent approaches evaluated remission 
of symptoms. Although only a few studies were pooled for secondary outcomes 
multicomponent BA improved functional outcomes, quality of life, and anxiety in the 
short term. It will be important for future trials to assess long-term effectiveness of BA 
for older people as a stand-alone intervention.     
     Data on effectiveness of BA in inpatient and long-term care settings did not show that 
BA decreased depressive symptoms, however the majority of studies were small and of 
lower quality. We found three trials evaluating BA-related interventions for people with 
dementia. These studies however did not employ theoretically driven and structured 
approaches of BA, or included strong components of physical activity thereby limiting 
the conclusions of effectiveness of BA per se. 
     We found that the studies evaluating BA for older people differed in terms of 
inclusion criteria. Although using broad inclusion criteria can be an advantage producing 
treatments that are more generalisable, the participants in the studies varied between 
people with or without a depression diagnosis and intervention delivery of BA (delivered 
by mental health workers versus self-help interventions). Self-help BA may be an 
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impractical intervention for the most severely depressed people who are particularly 
lacking in energy and motivation and may be restricted in going out from care settings 
because of concerns about self-harm. Our multicomponent BA, inpatient and long-term 
care meta-analyses included studies with varied participants in terms of medical 
comorbidity, and cognitive impairment. It has been argued that this complex interactive 
factors of medical morbidity, cognitive impairment, and psychological factors may make 
depression in late life difficult to treat. Therefore our findings are important in that they 
are suggestive that BA interventions may be able to address the complexity of preventing 
and treating depressive symptoms in older people.  
Quality of the evidence 
      Risk of bias was unclear for multiple domains in some of the studies, with published 
information sometimes insufficient to determine risk of bias. Only the area of selective 
reporting was judged as low risk in all studies. Most of the studies had uncertainties on 
the areas of random sequence generation, and allocation concealment. Based on the 
GRADE system, we have classified the quality of the evidence as 'moderate'. Although 
publication bias did not have a significant effect on the results, we found that the effects 
of BA may be overestimated when including small studies. However, our analyses are 
based on a limited number of trials overall, and we were unable to conduct other 
sensitivity analyses because of lack of power of potential comparisons.  
     This review has several limitations. The studies had a relatively low age criteria with 
many including adults aged 55 and over and the highest age criteria being aged over 65. 
Many participants would therefore be less likely to have the typical circumstances of 
older people including multiple physical comorbidities and no longer working. Our test of 
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publication bias does not provide direct evidence of no bias present; therefore it is likely 
that the studies overestimate the true effect size of BA for older people.  
     Some of the studies investigated bibliotherapy as a treatment for late life depressive 
symptoms which may limit its use in some settings. Although all studies used central 
components of BA approaches such as structured pleasant activity scheduling and mood 
monitoring, some report on the use of additional behavioral strategies which limits our 
understanding of which specific components are important (12). High heterogeneity may 
have contributed to our lack of group differences in some of the outcomes and the 
comparison to waiting-list control conditions in some of the studies may have 
overestimated the effects. We also could not find information on co-existent anxiety 
disorders. Although there was a wide range of depression severity within studies, this 
range may enable findings to be generalisable to a large proportion of older people who 
are likely to seek treatment.  
     Implications for practice and research 
     This is the first systematic review of BA for depression in older people which 
followed guidelines set out by the Cochrane Collaboration. We used a comprehensive and 
sensitive strategy to identify studies, and selection of studies, data extraction, and 
assessments of risk of bias were independently conducted by two authors. Our findings 
are in line with evidence that BA may be associated with medium to large effects, being 
observed in relatively few sessions delivered by junior mental health workers (11). Most 
of the studies included an average of 8-10 sessions across all settings of BA, implemented 
primarily by non-mental health specialists. We also found that BA interventions 
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improved other outcomes such as quality of life, functional disability, and decreased 
anxiety symptoms in the short-term.  
     Currently, management of late-life depression with or without cognitive impairment is 
limited to the prescription of antidepressants where there may be poor adherence or 
inconclusive evidence of effectiveness (6, 44). Our data show that high quality mental 
health care for treating or preventing clinically significant symptoms of depression in 
older people may benefit from individualised treatments that emphasise pleasant 
activities. There is a need however for well-designed multicentre RCTs which adhere to 
high standards of methodology and reporting. These trials should focus on theoretically 
driven BA interventions.  
     The lack of follow-up data poses limitations in terms of informing evidence-based 
policy about how best to deliver BA for older people, and there are no data on cost-
effectiveness. Future studies should examine long-term effects. There remains a need for 
carefully designed studies of interventions for older people with cognitive impairment 
and dementia, and considering evaluation of BA separately for older people with and 
without cognitive impairment as findings may differ.  
Conclusion  
     Results showed that BA interventions are superior to usual care in reducing depressive 
symptoms in older people living in the community, although we were not able to 
investigate whether they are superior to active controls. Multicomponent BA reduced 
depressive symptoms post treatment, and improved remission both short term and long-
term. On the basis of this meta-analysis we conclude that although BA may be a 
potentially effective treatment for mild or subthreshold symptoms and major depression 
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in older people, evidence remains limited. Our review suggests that additional 
components to BA such as care collaboration or case management may not add to 
effectiveness. Given the small number of RCTs and presence of bias in studies, effects 
associated with BA should be interpreted with caution. Future large scale studies are 
necessary to establish effectiveness of these approaches for older people.   
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Figure 1 
Study flow diagram 
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Figure 2: Forest plot of BA versus treatment as usual for older people living in the community with a diagnosis of 
depression or depressive symptoms. Outcome: Depressive symptoms (4-12 weeks). 
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Figure 3: Forest plot of multicomponent BA versus treatment as usual for older people living in the community with a diagnosis of 
depression or depressive symptoms. Outcome: Depressive symptoms (3-6 months). 
 
 
 
 
 
Figure 4: Forest plot of multicomponent BA versus treatment as usual for older people living in the community with a diagnosis of 
depression or depressive symptoms. Outcome: Depressive symptoms (8-12 months). 
Behavioral Activation in Late Life 27 
Search Strategy of the Review 
1. (behavio$ adj activati$).ti,ab. 
 
2. (activity adj scheduling).ti,ab. 
 
3. (pleasant event$ or pleasant activit$ or daily diar$).ti,ab. 
 
4. (behavio$ adj therap$).ti,ab. 
 
5. exp behavior therapy/ 
 
6. 1 or 2 or 3 or 4 or 5 
 
7. exp Aged/ 
 
8. Elder*.mp.  
 
9. Geriatri*.mp.  
 
10. Senil*.mp.  
 
11. Older.mp.  
 
12. Old Age.mp. 
 
13. Late Life.mp.  
 
14. Aged, 80-And-Over.mp.  
 
15. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 
 
16. randomized controlled trial.pt. 
 
17. controlled clinical trial.pt. 
 
18. randomized.ab. 
 
19. randomised controlled trial.tw. 
 
20. random*.ab. 
 
21. randomly.ab. 
 
22. trial.ab. 
 
23. groups.ab. 
 
24. 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 
 
25. 6 and 15 and 24 
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Table 1 Characteristics of Included Studies  
Study Sample Method Measures Intervention 
 
Outcome Data Timepoints 
 
 
BA in older people living in the community (with depressive symptoms or a diagnosis of depression) vs TAU or other psychological intervention (one study only) 
Gallgher & 
Thompson 1982 
n = 30  
Inclusion criteria 
1) aged  ≤  55  
2) MMSE ≤ 25 
3) BDI < 17/HRSD < 17 
RCT 
Control group 
Brief relational 
insight therapy  
Primary outcome 
HAM-D  
 
 
 
Intervention  
BA (referred to as behaviour therapy) 
– Increasing pleasant events daily, monitoring of 
mood, relaxation & social skills training 
Duration 
16  individual sessions over 12 weeks (90 mins)  
 
Outcome data included in the 
Review 
 
3 months 
 
 
Thompson & 
Gallagher 1984 
n = 43 
Inclusion criteria 
1) aged   ≤ 60  
2) MDD (RDC) 
6) MMSE ≤ 25 
 
RCT 
Control group 
Delayed 
treatment 
control 
Primary outcome 
HAM-D 
Intervention  
BA (referred to as behaviour therapy)  
– Increasing pleasant events daily, monitoring of 
mood, relaxation & social skills training 
Duration 
16-20 individual sessions over 6 weeks 
Outcome data included in the 
Review 
 
6 weeks  
 
 
Scogin 1989 
 
 
n = 40 
 Inclusion criteria 
1) HRSD ≤ 10 
2) MSQ ≤ 8  
RCT 
Control group 
Delayed 
treatment 
control 
Primary outcome 
HRSD  
 
Intervention  
BA bibliotherapy (Control Your Depression –
Lewinsohn et al), pleasant activity scheduling, 
learning to relax, social skills, modification of self-
defeating thoughts 
Duration 
Several ‘chapters’ over 4 weeks  
Outcome data included in the 
Review 
 
4 weeks  
 
Moss et al 2012  
 
n = 26  
Inclusion criteria 
1) aged ≤ 55  
2) GDS ≤ 5 
3) TICS-M ≤ 33 
RCT 
Control group 
Delayed 
treatment 
control 
Primary outcome 
HRSD  
 
Intervention  
BA bibliotherapy (Addis & Martell’s Overcoming 
depression one step at a time), pleasant activity 
scheduling and mood monitoring  
Duration 
Self-paced course over 4 weeks  
Outcome data included in the 
Review 
 
4 weeks 
 
Cernin 2009 
 
n = 15  
Inclusion criteria 
Older adults living in assisted 
living housing   
RCT 
Control group 
Waiting list 
Primary outcome 
GDS   
 
Intervention 
Pleasant activities scheduling, monitoring of mood, 
controlled breathing, visual imagery (Lichtenberg et 
al.)    
Duration 
Outcome data included in the 
Review 
 
3 months  
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36 sessions over 12 weeks (lasting 30 minutes) 
 
Multicomponent BA for older people in the community 
 
Ciechanowski 
2004 
n = 138 (mostly homebound 
& medically ill) 
Inclusion criteria 
1) aged ≤ 55  
2) DSM-IV minor depression 
or dysthymia 
RCT 
Control group 
TAU 
Primary outcome 
HSCL-20  
 
Intervention 
PEARLS (Program to Encourage Active, Rewarding 
Lives for Seniors), medication review, increasing 
pleasant activities, monitoring of mood, PST, 
increasing physical and social activity   
Duration 
8 sessions over 19 weeks on average (of 50 minutes)  
Outcome data included in the 
Review 
 
6 & 12 months  
 
Unützer 2002 
n = 1801  
Inclusion criteria 
1) aged ≤ 60  
2) SCID major depression 
and/or dysthymia 
RCT 
Control group 
TAU 
Primary outcome 
SCL-20  
 
Intervention 
IMPACT (Improving Mood-Promoting Access to 
Collaborative Care Treatment), care management, 
biopsychosial history, pleasant activity scheduling,  
medication review and/or PST  
Duration 
Weekly contact for an average of 6-8 weeks 
Outcome data included in the 
Review 
 
3 & 12 months  
 
Gitlin et al. 
2013 
 
n = 208 (African Americans) 
Inclusion criteria 
1) aged ≤ 55  
2) PHQ-9 ≤ 5  
3) MMSE ≤ 24 
RCT 
Control group 
Wait-list 
control 
Primary outcome 
Depression severity 
PHQ-9  
 
Intervention  
BTB (Beat the Blues) incorporating care 
management, pleasant activity goals, mood 
monitoring, addressing environmental barriers, stress 
reduction  
Duration 
10 in home sessions (1 hour) weekly 
 
Outcome data included in the 
Review 
  
4 & 8 months 
Gilbody et al. 
2017 
 
n = 705  
Inclusion criteria 
1) aged ≤ 65  
2) DSM-IV subthreshold 
depression (MINI)   
 
RCT 
Control group 
Usual primary 
care 
Primary outcome 
Depression severity 
PHQ-9  
 
Intervention  
CASPER (Collaborative Care for Screen Positive 
Elders) incorporating care management, pleasant 
activity scheduling, monitoring of mood and 
rewarding activities, addressing avoidance of social 
interactions 
Duration 
6 sessions (1 face to face and subsequent sessions by 
phone) weekly 
 
 
Outcome data included in the 
Review 
  
4 & 12 months 
BA in older people in inpatient settings 
 
Sood 2003 n =14 (inpatients of 
rehabilitation unit)  
Inclusion criteria 
1) aged ≤  60 
RCT 
Control group 
Standard 
occupational 
Primary outcome 
Depression 
GDS 
 
Intervention  
GWP (Geriatric Welleness Program), increasing 
pleasurable activities, mood monitoring, relaxation/ 
stress reduction (controlled breathing, visualisation 
Outcome data included in the 
Review 
 
Post intervention  (no further 
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 therapy exercises)  
Duration 
4 sessions weekly (30-60 minutes) over 7.5 weeks 
details provided) 
Norton 2010 n = 50 (inpatients of 
psychiatric hospital)  
Inclusion criteria 
1) aged ≤  65 
2) GDS ≤ 9/TICS-m ≤ 20  
 
RCT 
Control group 
Treatment as 
usual 
Primary outcome 
Depression 
GDS 
 
 
 
Intervention  
BATD (Brief Behavioral Activation Therapy), 
monitoring of pleasant activities and mood, 
identifying life areas of improvement 
Duration 
8 group sessions over 2 weeks 
Outcome data included in the 
Review 
 
Post intervention  (no further 
details provided) 
 
Snarksi 2011 
 
n = 50 (inpatients with mild/ 
moderate cognitive 
impairment) 
Inclusion criteria 
1) aged ≤ 65  
2) GDS-S ≤ 3  
3) MMSE ≤ 18 
RCT 
Control group 
Treatment as 
usual 
Primary outcome 
Depression 
GDS-S  
 
Intervention  
Increasing frequency and duration of activities in line 
with life goals, mood monitoring, setting goal 
hierarchies 
Duration 
8 sessions, biweekly (30-60 minutes) over 4 weeks 
Outcome data included in the 
Review 
 
4 weeks 
 
 
BA for older people living in care 
 
Lichtenberg 
2005 
n = 20  older people with AD 
or other dementia diagnosis 
Inclusion criteria 
Not specified 
RCT 
Control group 
TAU 
Primary outcome 
Depression 
GDS 
 
Intervention  
Increasing pleasant activities, mood monitoring, 
breathing relaxation/imagery exercises 
Duration 
3 times a week (20-30 minutes sessions) over 3 
months 
Outcome data included in the 
Review 
 
3 months 
Meeks et al 
2008 
 
n = 20   
Inclusion criteria 
1) SADS & DSM-IV major 
depressive disorder/minor 
depression/intermittent 
depressive disorder 
2) GDS ≤ 11  
3) MMSE < 13 
RCT 
Control group 
TAU 
Primary outcome 
Depression 
HDRS 
 
Intervention  
BE-ACTIV (Behavioral Activities-based 
intervention), scheduling and increasing pleasant 
events, goal re-evaluation, confronting obstacles, 
maintaining gains 
Duration 
10 individual 30-40 minutes sessions weekly over 10 
weeks 
 
Outcome data included in the 
Review 
 
6 weeks 
Hyer et al., 2009 n = 25 
Inclusion criteria 
1) DSM-IV depression 
diagnosis  
2) GDS-S ≤ 5  
3) MMSE ≤ 18 
RCT 
Control group 
Treatment as 
usual 
Primary outcome 
Depression 
GDS-S 
 
Intervention  
GIST (Group, Individual and Staff Therapy),  
increasing positive mood through pleasant activities, 
goal setting, & social support 
Duration 
13 group & 2 individual sessions (75 to 90 minutes ) 
Outcome data included in the 
Review 
 
Post intervention 
(approximately at 13 weeks)  
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 weekly over 13 weeks 
Dozeman 2011 n = 129  
Inclusion criteria 
1) CES-D ≤ 8 
 
 
RCT 
Control group 
Usual care 
(regular 
activities in the 
home) 
Primary outcome 
Depression 
CES-D 
 
 
 
Intervention  
Self-help BA (Activity Scheduling of the Coping 
with Depression – CWD course - Haringsma et al 
2006), pleasurable activity scheduling and 
monitoring of mood 
Duration 
Self-paced over 4 weeks  
Outcome data included in the 
Review 
 
3 months  
 
 
Verkaik 2011 
 
n = 97 older people with 
dementia 
Inclusion criteria 
1) dementia diagnosis  
2) PDC-dAD depression  
3) verbal communication   
RCT 
Control group 
TAU 
Primary outcome 
Depression 
CSDD 
 
Intervention  
Increasing pleasant activities, decreasing unpleasant 
events and maintain activities in every day life 
Duration 
Several sessions mostly training of nurses over 11 
weeks (no further details provided) 
Outcome data included in the 
Review 
 
12 weeks 
Meeks et al., 
2015 
 
n = 82 
Inclusion criteria 
1) aged ≤ 55  
2) DSM-IV depressive 
disorder or GDS ≤ 11  
Cluster RCT 
Control group 
TAU (staff 
training in 
dementia/ 
managing 
behaviour 
problems) 
Primary outcome 
Depression 
GDS 
 
 
Intervention  
BE-ACTIV (Behavioral Activities Intervention), 
reinforcing pleasant activities, depression 
management, confronting obstacles 
Duration 
Weekly individual sessions over 10 weeks  
 
Outcome data included in the 
Review 
 
12 weeks 
 
BA-related interventions in people with dementia living in the community (encouraged activities not in line with BA model and associated behavioral strategies) 
 
Teri 1997 
n = 72 
Inclusion criteria 
1) dementia diagnosis    
2) DSM-III-R/RDC 
major/minor depressive 
disorder  
RCT 
Control group 
TAU 
Primary outcome 
Depression   
CSDD & HRDS 
 
Intervention  
BT-PE (Behavior Therapy-Pleasant Events), 
teaching carers behavioural strategies to address 
problem behaviors including depression, increasing 
pleasant events, problem-solving, addressing carer 
stress and burden 
Duration 
9 (60 minutes) sessions over 9 weeks  
Outcome data 
 
Post intervention  
9 weeks 
 
Teri 2003 
n = 153 
Inclusion criteria 
1) NINDS-ADRDA criteria 
2) family carer     
2) living in the community 
RCT 
Control group 
TAU (routine 
medical care) 
Primary outcome 
Depression   
CSDD & HRDS 
 
Intervention  
RDAD (Reducing Disability in Alzheimer’s disease), 
increasing pleasant events, and modifying problem 
behaviours, increasing exercise, carer 
psychoeducation  
Duration 
12 (1 hour) sessions over 3 months  
Outcome data 
 
3 months 
 n = 209 RCT Primary outcome Intervention  Outcome data 
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Giltin 2010 Inclusion criteria 
1) dementia diagnosis or 
MMSE < 24    
2) required assistance with 
daily activities/behaviour 
symptoms 
Control group 
Education 
materials 
Function  
FIM 
 
COPE (Care of Persons with Dementia in their 
Environments), reducing environmental stressors, 
identifying deficits and capabilities, engaging 
patients in activities based on strengths and interests 
Duration 
10 sessions over 4 months  
 
4 months 
Note: MMSE - Mini-Mental State Examination; BDI-II - Beck Depression Inventory-II; HAM-D/HRSD/HDRS - Hamilton Rating Scale for Depression; MDD - Major Depressive Disorder; RDC - 
Research Diagnostic Criteria; MSQ - Mental Status Questionnaire; GDS – Geriatric Depression Scale; TICS-M - Modified Telephone Interview for Cognitive Status; DSM-IV - Diagnostic and Statistical 
Manual of Mental Disorders-Fourth Edition; HSCL-20 - Hopkins Symptom Checklist Depression Scale; SCID-5 - Structured Clinical Interview for DSM-5; SCL-20 - Symptom Checklist Depression 
Scale; PHQ-9 - Patient Health Questionnaire; MINI – Mini International Neuropsychiatric Interview; GDS-S - Geriatrics Depression Scale Short-Form; SADS - Schedule for Affective Disorders and 
Schizophrenia; CES-D - Center for Epidemiological Studies-Depression; PDC-dAD - Provisional Diagnostic Criteria for Depression of Alzheimer disease; CSDD – Cornell Scale for Depression in 
Dementia; DSM-III-R - Diagnostic & Statistical Manual of Mental Disorders–3rd Edition Revised; NINCDS-ADRDA - National Institute of Neurological and Communicative Disorders and Stroke and 
the Alzheimer's Disease and Related Disorders Association; FIM – Functional Independence Measure.  
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Table 2 Excluded Studies 
 
  
Study 
 
Reason for Exclusion  
  
 
 
 
 
1 
 
Steffen 2016 
 
RCT of a behavioural intervention incorporating BA, relaxation and management of behaviour problems in dementia in carers 
of people with neurocognitive disorder  
2 Egede 2015 Randomised controlled open-label, non-inferiority trial, of telemedicine-delivered vs face to face BA in veterans   
3 Alexopoulos 2015 Not a RCT (open treatment trial),  Problem Solving Therapy (PST) in older adults with major depression compared with 
historical comparison group 
4 Kiosses 2015 RCT of Problem adaptation therapy vs supportive therapy in older adults with cognitive impairment  
5 Choi 2014 RCT of tele-PST vs in person PST vs telephone support calls in depressed low income homebound older adults 
6 Moore 2013 RCT of BA vs information support in family carers of people with dementia 
7 Acierno 2012 Controlled before-and-after study of BA and therapeutic exposure for bereavement in older adults with MDD and PTSD 
8 Losada 2011 RCT of BA and cognitive restructuring in carers of people with dementia 
9 van't Veer-Tazelaar 2015 RCT of minimally supported self-help CBT, problem-solving treatment, and referral to a primary care physician for 
medication for older people with subthreshold depression or anxiety 
10 Alexopoulos 2011 PST vs supportive therapy for older people with major depression and executive dysfunction  
11 Sriwattanakomen 2008 RCT of PST with BA components vs a dietary education control condition in older black and white older adults with 
subthreshold depressive symptoms no data available 
12 Gant 2007 RCT of BA in family carers of people with dementia incorporating improving mood through pleasant activities and managing 
problem behaviours    
13 Götestam 1990 RCT of prompting and reinforcing activities in people with dementia vs prompting only vs control in which activities were not 
based on a BA model but on general activity training 
14 Prick 2015 Multicomponent dyadic intervention in dementia caregiving dyads incorporating BA for the person with dementia, evaluated 
carer outcomes only 
15 Lichtenberg 1996  Controlled trial (non RCT) of 2 behavioural treatments (selecting pleasant events, planning positive reinforcement strategies, 
and receiving support and reinforcement) in older inpatients with hip fracture, arthritis, and gait disturbances  
16 Brand 1992 Controlled trial (non RCT) of group behavior therapy vs control in inpatient older adults with major depression    
17 Clignet 2012 Case study of implementation of the Systematic Activation Method (SAM) incorporating activity scheduling as a nursing 
intervention in inpatients     
18 Turner 2010 Case studies of BATA (Behavioral Activation Treatment of Anxiety) in older people  
19 Guirguis-Younger 2008 Before-after experimental series design study of a behavioural-based intervention incorporating reinforcement of pleasant 
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activities for older adults with depression 
20 Thompson & Gallagher 
1983 
Before after study testing feasibility of a behaviourally oriented course of mood monitoring and learning to identify, record and 
monitor everyday pleasant activities in older adults 
21 Teri 1991 Case studies investigating the relationship between pleasant activities and depression in people with dementia and depression 
by teaching carers to increase pleasant experience for the patient and decrease behavioural disturbances 
22 Floyd 2004 RCT of cognitive bibliotherapy vs individual cognitive psychotherapy vs delayed treatment control in older people with 
depression 
23 Yon & Scogin 2009 Before and after study of BA in older adults with depression 
24 Teri 1991 Case study of behavioural treatment of depression in older people 
25 Gallagher 1981 RCT of a behavioural intervention aimed at improving social skills and increasing the frequency of engagement of pleasant 
activities vs supportive group psychotherapy in older people with moderate to severe depression (no control group), no data 
available 
26 Scogin 1987 Before and after study of cognitive bibliotherapy in older people with depression 
27 Breckenridge 1987 Feasibility before and after study of the Life Satisfaction Course in older people with dysphoria   
28 Jimenez 2015 Ongoing RCT of a health promotion intervention incorporating BA with a large physical activity component for older Latinos 
with subthreshold depression or anxiety  
29 Quijano 2007 Controlled before-and-after study of an intervention incorporating education, referral and linkage with services and BA in 
high-risk older adults provided by case managers 
30 Au 2015 RCT of telephone-assisted BA in Chinese family carers of people with dementia vs psychoeducation 
31 Mausback 2014 RCT of BA in family carers of people with dementia vs support vs information  
32 Sallis 1983 Controlled trial of depression management based on BA vs usual care 
33 Vázquez 2015 RCT of BA vs CBT vs TAU in family carers of dependent family members 
34 Lovett 1998 RCT evaluating the Life Satisfaction course focusing on increasing pleasant events in carers of dependent older adults vs 
waiting list 
35 Alexopoulos 2003 RCT PST vs supportive therapy for older people with major depression and executive dysfunction  
36 Rokke 1999 Self-help BA vs Cognitive Therapy (CT) for older people with depression, not all participants randomised  
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Figure 5: Forest plot of multicomponent BA versus treatment as usual for older people living in the community with a diagnosis of 
depression or depressive symptoms. Outcome: Remission of depressive symptoms (3-6 months). 
 
 
Figure 6: Forest plot of multicomponent BA versus treatment as usual for older people living in the community with a diagnosis of 
depression or depressive symptoms. Outcome: Remission of depressive symptoms (8-12 months). 
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Figure 7. Risk of bias graph: review authors' judgements about each risk of bias item presented 
as percentages across all included studies. 
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Figure 8: Funnel Plot as indicator of publication bias: All BA studies in older people, without imputed studies 
 
 
 
